tiprankstipranks
Trending News
More News >
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market
Advertisement

Marvel Biosciences Corp (MRVL) Financial Statements

Compare
28 Followers

Marvel Biosciences Corp Financial Overview

Marvel Biosciences Corp's market cap is currently C$9.53M. The company's EPS TTM is C$-0.006; its P/E ratio is ―; Marvel Biosciences Corp is scheduled to report earnings on June 17, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ -887.52KC$ -1.38MC$ -613.10KC$ -265.20K
Operating IncomeC$ -1.22KC$ -2.32MC$ -2.54MC$ 806.33KC$ -954.20K
EBITDAC$ -1.54MC$ -2.25MC$ -2.51MC$ -1.25MC$ -1.02M
Net IncomeC$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04MC$ -955.66K
Balance Sheet
Cash & Short-Term InvestmentsC$ 345.77KC$ 556.62KC$ 593.21KC$ 2.39MC$ 224.81K
Total AssetsC$ 491.31KC$ 672.39KC$ 913.54KC$ 2.47MC$ 295.99K
Total DebtC$ 1.71MC$ 1.00MC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ 1.36MC$ 443.38KC$ -593.21KC$ -2.39MC$ -224.81K
Total LiabilitiesC$ 3.32MC$ 2.39MC$ 718.00KC$ 112.48KC$ 177.18K
Stockholders' EquityC$ -2.83MC$ -1.72MC$ 195.54KC$ 2.36MC$ 118.80K
Cash Flow
Free Cash FlowC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37MC$ -538.53K
Operating Cash FlowC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37MC$ -538.53K
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 381.57KC$ 0.00
Financing Cash FlowC$ 968.64KC$ 1.30MC$ 394.00KC$ 3.16MC$ 763.17K
Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History

Marvel Biosciences Corp Debt to Assets

Marvel Biosciences Corp Cash Flow

Marvel Biosciences Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis